sodium tungstate(vi) has been researched along with phosphotyrosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baqué, S; Barberà, A; Caron, M; Domínguez, JE; Gomis, R; Guinovart, JJ; Mercurio, C; Muñoz, MC; Perona, R; Sanchez-Perez, I; Zafra, D | 1 |
1 other study(ies) available for sodium tungstate(vi) and phosphotyrosine
Article | Year |
---|---|
The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glucose; Glycogen; Hepatocytes; Humans; Hypoglycemic Agents; Immunoblotting; Insulin; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Receptor, Insulin; Time Factors; Transfection; Tungsten Compounds | 2003 |